drugset / Trial / NCT02927444

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

NCT02927444

Phase 3 Completed 462 enrolled SK Chemicals Co., Ltd.
RandomizedParallel-groupDouble-blindPrevention

Summary

This study will assess the immunogenicity and safety of booster vaccination with NBP606 compared to the existing commercial vaccine, when given concomitantly with routine pediatric vaccinations.

Timeline

Start
2015-11-04
Primary completion
2017-10-26
Completion
2017-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject NBP606 Unknown Intramuscular
Comparator Prevnar 13 Vaccine Intramuscular